Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raina N Fichorova

Showing results (1-10 of 139) with videos related to

Pageof 14
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|January 19, 2006
Guiding the vaginal microbicide trials with biomarkers of inflammationRaina N Fichorova
Journal of Reproductive Immunology|October 24, 2009
Impact of T. vaginalis infection on innate immune responses and reproductive outcomeRaina N Fichorova
Journal of Acquired Immune Deficiency Syndromes (1999)|January 19, 2006
Preclinical assessment of the proinflammatory potential of microbicide candidatesGustavo F Doncel, Neelima Chandra, Raina N Fichorova
BMC Microbiology|January 10, 2013
Homeostatic properties of Lactobacillus jensenii engineered as a live vaginal anti-HIV microbicideHidemi S Yamamoto, Qiang Xu, Raina N Fichorova
AIDS (London, England)|November 13, 2014
The vaginal microbiota and susceptibility to HIVAnne Buve, Vicky Jespers, Tania Crucitti, et al.
Anaerobe|July 1, 2019
Introduction to the special issue for The anaerobe society of the America's 14th Biennial congress in Las VegasLaura M Cox, Anna M Seekatz, Raina N Fichorova
Clinical Microbiology Reviews|February 12, 2016
The Human Microbiome during Bacterial VaginosisAndrew B Onderdonk, Mary L Delaney, Raina N Fichorova
Current Problems in Cancer|June 16, 2022
The vaginal microbiome: A complex milieu affecting risk of human papillomavirus persistence and cervical cancerStephanie Alimena, Joshua Davis, Raina N Fichorova, et al.
Antimicrobial Agents and Chemotherapy|October 13, 2006
Biocompatibility of solid-dosage forms of anti-human immunodeficiency virus type 1 microbicides with the human cervicovaginal mucosa modeled ex vivoRadiana T Trifonova, Jenna-Malia Pasicznyk, Raina N Fichorova
Cytokine|December 3, 2011
Relationships among the concentrations of 25 inflammation-associated proteins during the first postnatal weeks in the blood of infants born before the 28th week of gestationAlan Leviton, Elizabeth N Allred, Hidemi Yamamoto, et al.
Pageof 14

Showing results (1-10 of 139) with videos related to

Sort By:
Pageof 14
Journal of Acquired Immune Deficiency Syndromes (1999)|January 19, 2006
Guiding the vaginal microbicide trials with biomarkers of inflammationRaina N Fichorova
Journal of Reproductive Immunology|October 24, 2009
Impact of T. vaginalis infection on innate immune responses and reproductive outcomeRaina N Fichorova
Journal of Acquired Immune Deficiency Syndromes (1999)|January 19, 2006
Preclinical assessment of the proinflammatory potential of microbicide candidatesGustavo F Doncel, Neelima Chandra, Raina N Fichorova
BMC Microbiology|January 10, 2013
Homeostatic properties of Lactobacillus jensenii engineered as a live vaginal anti-HIV microbicideHidemi S Yamamoto, Qiang Xu, Raina N Fichorova
AIDS (London, England)|November 13, 2014
The vaginal microbiota and susceptibility to HIVAnne Buve, Vicky Jespers, Tania Crucitti, et al.
Anaerobe|July 1, 2019
Introduction to the special issue for The anaerobe society of the America's 14th Biennial congress in Las VegasLaura M Cox, Anna M Seekatz, Raina N Fichorova
Clinical Microbiology Reviews|February 12, 2016
The Human Microbiome during Bacterial VaginosisAndrew B Onderdonk, Mary L Delaney, Raina N Fichorova
Current Problems in Cancer|June 16, 2022
The vaginal microbiome: A complex milieu affecting risk of human papillomavirus persistence and cervical cancerStephanie Alimena, Joshua Davis, Raina N Fichorova, et al.
Antimicrobial Agents and Chemotherapy|October 13, 2006
Biocompatibility of solid-dosage forms of anti-human immunodeficiency virus type 1 microbicides with the human cervicovaginal mucosa modeled ex vivoRadiana T Trifonova, Jenna-Malia Pasicznyk, Raina N Fichorova
Cytokine|December 3, 2011
Relationships among the concentrations of 25 inflammation-associated proteins during the first postnatal weeks in the blood of infants born before the 28th week of gestationAlan Leviton, Elizabeth N Allred, Hidemi Yamamoto, et al.
Pageof 14